Development of bovine IVF oocytes cultured in medium supplemented with a nitric oxide scavenger or inhibitor in a co-culture system.
Bovine IVF oocytes were cultured in modified bovine embryo culture medium (mBECM) supplemented with either a nitric oxide (NO) scavenger, hemoglobin (Hb, 1 microg/mL) and/or a NO synthesis inhibitor, L(omega)-nitro-L-arginine methyl ester (L-NAME, 1 or 1000 nM) in a cumulus-granulosa cell co-culture system. In Experiment 1, a total of 1,675 cumulus-oocytes complexes was collected for 7 mo and cultured to the blastocyst stage in mBECM with or without Hb after IVM and IVF. There were significant (P<0.0024) model effects of Hb addition and month of oocyte collection on embryo development. A significant (P<0.0023) monthly variation was detected in all developmental stages. However, addition of Hb to mBECM consistently enhanced embryo development to the blastocyst stage over all months. No statistical differences were found in the interaction between Hb addition and month except for the cleavage rate. Overall, a greater percentage of oocytes developed to the 8-cell (P<0.0459), 16-cell (P<0.001), morula (P<0.0013) and blastocyst (P<0.0024) stages after the addition of Hb. In Experiment 2, addition of L-NAME to mBECM supplemented with Hb did not further stimulate prehatched development. In conclusion, the promoting effect of Hb on in vitro development of embryos is highly repeatable over an extended period of time.
Lim
J M
JM
Department of Reproductive Biotechnology, LSU-Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA.
Mei
Y
Y
Chen
B
B
Godke
R A
RA
Hansel
W
W
D000818:Animals; D001562:Benzimidazoles / Q000737:chemistry; D002417:Cattle / Q000196:embryology / Q000502:physiology*; D018920:Coculture Techniques; D003470:Culture Media; D005314:Embryonic and Fetal Development; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005260:Female; D005307:Fertilization in Vitro / Q000662:veterinary*; D005456:Fluorescent Dyes / Q000737:chemistry; D006454:Hemoglobins / Q000494:pharmacology*; D008297:Male; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology*; D009865:Oocytes / Q000187:drug effects / Q000502:physiology*; D011897:Random Allocation; D012621:Seasons
D001562:Benzimidazoles; D003470:Culture Media; D004791:Enzyme Inhibitors; D005456:Fluorescent Dyes; D006454:Hemoglobins; C017807:bisbenzimide ethoxide trihydrochloride; D019331:NG-Nitroarginine Methyl Ester